Novo Nordisk announced the results from the phase 3b STEP
Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more. Kuwait, 16 July 2025 Novo Nordisk today presented the results from the phase 3b STEP UP trial in Read More